CheckMate-915: does adjuvant CTLA-4 blockade play a role in resected melanoma?
Ann Transl Med
.
2023 Aug 30;11(10):370.
doi: 10.21037/atm-23-754.
Epub 2023 Mar 6.
Authors
David Su
1
,
Harriet Kluger
2
,
Sarah A Weiss
3
Affiliations
1
Section of Surgical Oncology, Yale University School of Medicine, New Haven, CT, USA.
2
Division of Medical Oncology, Yale University School of Medicine, New Haven, CT, USA.
3
Department of Medical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
PMID:
37675335
PMCID:
PMC10477634
DOI:
10.21037/atm-23-754
No abstract available
Keywords:
Adjuvant; ipilimumab; melanoma; nivolumab.
Publication types
Editorial
Comment
Grants and funding
UL1 TR001863/TR/NCATS NIH HHS/United States